Literature DB >> 34391817

Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis.

Francesca Romana Rizzo1, Livia Guadalupi2, Krizia Sanna1, Valentina Vanni3, Diego Fresegna3, Francesca De Vito4, Alessandra Musella5, Silvia Caioli4, Sara Balletta1, Silvia Bullitta2, Antonio Bruno6, Ettore Dolcetti6, Mario Stampanoni Bassi4, Fabio Buttari4, Luana Gilio4, Georgia Mandolesi5, Diego Centonze7, Antonietta Gentile3.   

Abstract

Exercise is increasingly recommended as a supportive therapy for people with Multiple Sclerosis (pwMS). While clinical research has still not disclosed the real benefits of exercise on MS disease, animal studies suggest a substantial beneficial effect on motor disability and pathological hallmarks such as central and peripheral dysregulated immune response. The hippocampus, a core area for memory formation and learning, is a brain region involved in MS pathophysiology. Human and rodent studies suggest that the hippocampus is highly sensitive to the effects of exercise, the impact of which on MS hippocampal damage is still elusive. Here we addressed the effects of chronic voluntary exercise on hippocampal function and damage in experimental autoimmune encephalomyelitis (EAE), animal model of MS. Mice were housed in standard or wheel-equipped cages starting from the day of immunization and throughout the disease course. Although running activity was reduced during the symptomatic phase, exercise significantly ameliorated motor disability. Exercise improved cognition that was assessed through the novel object recognition test and the nest building in presymptomatic and acute stages of the disease, respectively. In the acute phase exercise was shown to prevent EAE-induced synaptic plasticity abnormalities in the CA1 area, by promoting the survival of parvalbumin-positive (PV+) interneurons and by attenuating inflammation. Indeed, exercise significantly reduced microgliosis in the CA1 area, the expression of tumour necrosis factor (TNF) in microglia and, to a lesser extent, the hippocampal level of interleukin 1 beta (IL-1β), previously shown to contribute to aberrant synaptic plasticity in the EAE hippocampus. Notably, exercise exerted a precocious and long-lasting mitigating effect on microgliosis that preceded its neuroprotective action, likely underlying the improved cognitive function observed in both presymptomatic and acute phase EAE mice. Overall, these data provide evidence that regular exercise improves cognitive function and synaptic and neuronal pathology that typically affect EAE/MS brains.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Interleukin 1 beta (IL-1β); Long term potentiation (LTP); Microglia; Multiple Sclerosis (MS); Neurodegeneration; Parvalbumin-positive (PV+) GABAergic interneuron; Synaptic plasticity; Tumor necrosis factor (TNF); Voluntary running wheel

Mesh:

Year:  2021        PMID: 34391817     DOI: 10.1016/j.bbi.2021.08.212

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  3 in total

Review 1.  Complicated Role of Exercise in Modulating Memory: A Discussion of the Mechanisms Involved.

Authors:  Mahshid Ebrahimnejad; Paniz Azizi; Vahide Alipour; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Neurochem Res       Date:  2022-02-23       Impact factor: 3.996

2.  Aerobic Exercise Improves Type 2 Diabetes Mellitus-Related Cognitive Impairment by Inhibiting JAK2/STAT3 and Enhancing AMPK/SIRT1 Pathways in Mice.

Authors:  Lili Lin; Yonghua Wang; Wenli Xu; Chaolu Huang; Jinrong Hu; Xixi Chen; Xinhuang Lv; Yuelin Qin; Xiaoyong Zhao; Haiyan Li
Journal:  Dis Markers       Date:  2022-05-05       Impact factor: 3.434

3.  Exercise training for cognitive and physical function in patients with mild cognitive impairment: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Yue Zhou; Liang-da Li
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.